Trade NNNN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Anbio Biotechnology Class A (NNNN) is trading at US$3.59, down 2.45% today as of Nov 5, 16:00 EST. The company has a market capitalisation of US$298.9M. Over the past 52 weeks, NNNN has traded between US$3.09 and US$44.73. On Syfe you can trade NNNN with $0 commission and add it to your watchlist.
| Previous close | US$3.68 |
|---|---|
| Market cap | US$298.9M |
| 52-week range | US$3.09 – US$44.73 |
| Volume | 33.66K |
| Exchange | US |
Anbio Biotechnology Class A
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
Year: 2025
Anbio Biotechnology Files Mixed Shelf Registration
Jul 9, 9:52 PM · MT Newswires
Anbio Biotechnology Class A (NNNN) stock is trading at US$3.59, -2.45% from the previous close of US$3.68.
The market cap for Anbio Biotechnology Class A (NNNN) stock is approximately US$298.9M.
The 52-week high for Anbio Biotechnology Class A (NNNN) stock is US$44.73.
The 52-week low for Anbio Biotechnology Class A (NNNN) stock is US$3.09.
Anbio Biotechnology Class A (NNNN) does not currently pay a dividend.
Stay on top of NNNN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
